p21 WAF1/CIP1 Expression is Differentially Regulated by Metformin and Rapamycin
International Journal of Chronic Diseases · 2014
DOI: 10.1155/2014/327640 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Chronic Diseases, 2014. Verfasst von Zoltan Molnar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Renal Unit and Diabetes Clinical Research Unit, Derriford Hospital, Plymouth, PL6 8DH, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The mammalian target of rapamycin (mTOR) pathway plays an important role in the development of diabetic nephropathy and other age-related diseases. One of the features of DN is the elevated expression of p21 WAF1/CIP1 . However, the importance of the mTOR signalling pathway in p21 regulation is poorly understood. Here we investigated the effect of metformin and rapamycin on mTOR-related phenotypes in cell lines of epithelial origin. This study reports that metformin inhibits high glucose-induced p21 expression. High glucose opposed metformin in regulating cell size, proliferation, and protein synthesis. These effects were associated with reduced AMPK activation, affecting downstream mTOR signalling. However, the inhibition of the mTOR pathway by rapamycin did not have a negative effect on p21 expression, suggesting that metformin regulates p21 upstream of mTOR. These findings provide support for the hypothesis that AMPK activation may regulate p21 expression, which may have implications for diabetic nephropathy and other age-related pathologies.
Autor:innen und Institutionen
- Renal Unit and Diabetes Clinical Research Unit, Derriford Hospital, Plymouth, PL6 8DH, UK.
Zitieren
APA
Molnar, Z., Millward, A. B., Tse, W., & Demaine, A. G. (2014). p21 WAF1/CIP1 Expression is Differentially Regulated by Metformin and Rapamycin. International Journal of Chronic Diseases. https://doi.org/10.1155/2014/327640
Vancouver
Molnar Z, Millward AB, Tse W, Demaine AG. p21 WAF1/CIP1 Expression is Differentially Regulated by Metformin and Rapamycin. International Journal of Chronic Diseases. 2014. doi:10.1155/2014/327640
BibTeX
@article{Molnar2014,
author = {Molnar, Zoltan and Millward, Ann B and Tse, Wai and Demaine, Andrew G},
title = {p21 WAF1/CIP1 Expression is Differentially Regulated by Metformin and Rapamycin},
journal = {International Journal of Chronic Diseases},
year = {2014},
doi = {10.1155/2014/327640}
}
EUVIMED